Barely Significant

Excerpts

514,629 sentences

an increasing trendp = 0.0080.2× alphagold
The segmented regression analysis (Figure 2 ) indicated no significant trend between PHQ‐9 score and BMI z ‐score when BMI < 2.68 (99.6th centile), but an increasing trend was observed when BMI z ‐score ≥ 2.68 (99.6th centile) (slope before breakpoint = 1.11 vs. after breakpoint = 12.89, p = 0.008).
borderline significantp = 0.0080.2× alphagold
Notably, the highest MCMI quartile still showed borderline significant heart disease risk in Model 3 (HR = 1.29, p = 0.008), implying MCMI captures unique metabolic dysregulation patterns/synergistic effects not fully reflected by individual traditional indicators.
highly significantp < 0.0080.2× alphaqualifiedgold
(Smoothed maps of the annualized, age-adjusted prostate cancer rates for all males in Virginia 1990–99 are shown in Figure 1 .) Statistical testing for global clustering was highly significant for the entire time period (Tango's Maximum Excess Events Test, p < 0.008) and for 1990–94 and 1995–99 separately (p < 0.001 for both).
highly significantP = 0.0080.2× alphaqualifiedgold
Compared to the null model (which included only the intercept term, assigning all patients the same baseline risk of 23.2%), the 24-week GPR model demonstrated highly significant reclassification improvement.: continuous NRI = 0.972 (95% CI: 0.000–1.160, P = 0.008), categorical NRI = 0.486 (95% CI: 0.259–0.711, P < 0.001), IDI = 0.024 (95% CI: 0.010–0.040, P = 0.002).
highly significantP = 0.0080.2× alphaqualifiedgold
The presence of aggregates at baseline was a highly significant predictor of the clinical response to anti-TNF treatment ( P = 0.008), demonstrating that RA patients with synovial lymphocyte aggregates may have a better response to Infliximab treatment than those with only diffuse leucocyte infiltration [ 59 ].
Advances in rheumatology: new targeted therapeutics.
Arthritis Res Ther · 2011 · PMC3123966
marginally significantP = 0.0080.2× alphagold
Clinically, these variants are associated with increased cardiovascular disease (CVD) risk; a 2023 meta-analysis of 66 studies ( n = 37,263) demonstrated that C677T carriers have a 13–20% higher odds of myocardial infarction (MI) under dominant (OR = 1.16, 95% CI:1.06–1.28, P = 0.008) and recessive (OR = 1.20, 95% CI:1.12–1.28, P < 0.001) models, with similar but marginally significant associations for A1298C (recessive OR = 1.27, 95% CI:1.06–1.51, P = 0.008), underscoring the need for genetic screening in CVD prevention [ 44 ].